【レポートの概要（一部）】
Table of Contents
1 Introduction (Page No. – 21)
1.1 Objectives Of The Study
1.2 Markets Covered
1.3 Stakeholders
1.4 Market Scope
2 Research Methodology (Page No. – 25)
2.1 Market Size Estimation
2.2 Market Crackdown And Data Triangulation
2.3 Market Share Estimation
2.3.1 Key Data From Secondary Sources
2.3.2 Key Data From Primary Sources
2.3.3 Assumptions
2.3.3.1 Key Industry Insights
3 Executive Summary (Page No. – 31)
4 Premium Insights (Page No. – 35)
4.1 Attractive Market Opportunities In The Next-Generation Sequencing (NGS) Market
4.3 Nxt Generation sequencing Market, By Product Segment
4.4 NGS Platform Market Size (Units)
4.5 NGS Market Growth Opportunities, By Geography
4.6 Life Cycle Analysis, By Geography
4.7 NGS Market In Asian Region
4.8 Company Market Share Analysis, By Geography
4.9 NGS Market, By Application
5 Market Overview (Page No. – 43)
5.1 Introduction
5.2 Evolution
5.3 Market Segmentation
5.4 Market Dynamics
5.4.1 Drivers
5.4.1.1 Cost And Speed To Drive The Growth Of NGS Technology
5.4.1.2 Substitution Of Microarray Technology By NGS To Boost Market Growth
5.4.1.3 Embracement Of NGS Technology By New Consumers To Propel The Market
5.4.1.4 Increase In Practice For New Scientific Applications To Boost Growth Of NGS Market
5.4.1.5 Research Laboratories And Academicians Promoting NGS
5.4.1.6 Global Alliances AmoNGSt Leading Research Institutes To Trigger Drug Discovery, Thus Increase The Demand Of NGS
5.4.1.7 Entry Of New Players Propelling The Growth Of The NGS Market
5.4.2 Restraints
5.4.2.1 High Reliability On Grants To Restrict Growth
5.4.2.2 Decrease In Capital Expenditure From Academic Institutes To Hinder The Sale Of Platforms
5.4.2.3 Accuracy & Standardization Concerns In Diagnostic Testing
5.4.2.4 Ethical And Legal Issues Related To Next-Generation Sequencing To Hinder The Adoption, Albeit To A Less Extent
5.4.3 Opportunities
5.4.3.1 Personalized Medicine & Biomarker Discovery Open Avenues For Investments In NGS Technology
5.4.3.2 Pre-Sequencing A High Growth Opportunity
5.4.3.3 Cloud Computing, A Prospective Service
5.4.4 Challenges
5.4.4.1 Interpretation Of Complex Data From NGS Platforms
5.4.5 Market Trend
5.4.5.1 Shift Of Focus Towards Third-Generation Sequencing
5.4.6 Burning Issues
5.4.6.1 Data Storage An Impediment To NGS Sequencing
5.4.6.2 Reduction In Cost To Sequence Human Genomes
5.4.7 Winning Imperative
5.4.7.1 Improved Collaborative Ties Between Industry And Academic & Research Institutes
6 Industry Trends (Page No. – 56)
6.1 Value Chain Analysis
6.2 Porter’s Five Forces Analysis
6.2.1 Threat From New Entrants
6.2.2 Threat From Substitutes
6.2.3 Bargaining Power Of Buyers
6.2.4 Bargaining Power Of Suppliers
6.2.5 Competitive Rivalry Among Exisiting Firms
6.3 Technological Development Road-Map
6.3.1 Sanger Sequencing
6.3.2 Massively Parallel Sequencing (Next Generation Sequencing)
6.3.3 Single Molecule Real Time (Smrt) Sequencing
6.3.4 Nanopore Sequencing
6.4 Technological Trends
6.4.1 Nanopore Sequencing Technology
6.4.1.1 Oxford Nanopore Technologies
6.4.1.2 Roche (Genia Technologies)
6.4.1.3 Electronic Biosciences
6.4.2 Sequencing By Hybridization Technology (Gnubio)
6.4.3 Genius (Gene Electronic Nano-Integrated Ultra-Sensitive) Technology (Genapsys)
6.4.4 Lightning Terminator Sequencing Technology (Lasergen)
6.4.5 Optical Nanopore Sequencing Technology (Noblegen)
6.4.6 Nanowire Biosensor Sequencing Technology (Quantumdx)
7 Global NGS Market, By Steps In Workflow (Page No. – 61)
7.1 Introduction
7.2 Pre-Sequencing Products & Services Market
7.2.1 Sample Preparation
7.2.1.1 DNA Fragmentation, End Repair, A-Tailing And Size Selection
7.2.1.2 Library Preparation
7.2.1.3 Target Enrichment
7.2.1.4 Quality Control
7.3 Sequencing Platforms Market
7.3.1 Illumina
7.3.1.1 Hiseq Series
7.3.1.2 Hiseq X Ten
7.3.1.3 Genome Analyzer Iix
7.3.1.3.1 Low Technological Advancements Will Result Into Downfall Of Ga Iix
7.3.1.4 Miseq
7.3.1.5 Nextseq500
7.3.2 Thermo Fisher Scientific (Life Technologies)
7.3.2.1 Solid Series
7.3.2.1.1 Solid Series Shows Minimal Scope For Growth
7.3.2.2 Ion Torrent Platforms
7.3.2.2.1 Ion Torrent Pgm
7.3.2.2.1.1 Currently Ion Torrent Pgm Exceeds The Unit Sales As Compared To Its Competitor Miseq
7.3.2.2.2 Ion Proton
7.3.2.2.2.1 Ion Proton Will Be One Of The Fast Growing Platforms
7.3.3 454 Roche
7.3.3.1 GS Junior Sales Stopped In 2013 And GS Flx+ Will Grow At Slow Pace Till 2016
7.3.3.2 GS Junior
7.3.3.3 GS Flx+
7.3.4 Pacific Biosciences
7.3.4.1 Pacbio Rs Ii
7.4 Sequencing Services Market
7.5 NGS Data Analysis, Storage, And Management (Bioinformatics) Market
7.5.1 Open-Source Applications Contribute 75% To The Overall NGS Bioinformatics Solutions Market
7.5.2 NGS Data Analysis, By Product
7.5.2.1 NGS Data Analysis Software & Workbenches
7.5.2.2 NGS Data Analysis Services
7.5.3 NGS Data Analysis, By Application
7.5.3.1 Whole-Genome Sequencing
7.5.3.2 Exome Sequencing
7.5.3.3 Targeted Re-Sequencing
7.5.3.4 De Novo Sequencing
7.5.3.5 RNA-Seq
7.5.3.6 Chip-Seq
7.5.3.7 Methyl-Seq
7.5.3.8 Others
7.5.4 NGS Storage, Management & Cloud Computing Solutions
8 Next Generation Sequencing Market, By Technology (Page No. – 109)
8.1 Introduction
8.2 Sequencing By Synthesis (Sbs)
8.2.1 Sbs To Be The Fastest-Growing Technology
8.3 Ion Semiconductor Sequencing
8.3.1 Ion Semiconductor Sequencing, A Fast-Growing Market
8.4 Sequencing By Ligation (Sbl)
8.4.1 Sbl Technology To Witness Negative Growth
8.5 Pyrosequencing
8.5.1 Pyrosequencing To Grow At A Negative Rate
8.6 Single Molecule Realtime Sequencing (Smrt)
8.6.1 Smrt Technology Has Limited Applications
9 Global NGS Application Market (Page No. – 117)
9.1 Introduction
9.2 Diagnostics
9.2.1 Diagnostics Market Will Grow With Addition Of Wider Applications
9.2.2 Cancer Diagnostics To Drive The Market
9.3 Drug Discovery
9.3.1 Focus On Targeted Therapy To Boost The Next Generation Sequencing Market
9.4 Biomarker Discovery
9.4.1 Biomarker Discovery Application To Grow At A High Rate
9.5 Personalized Medicine
9.5.1 Personalized Medicine Offers Huge Potential Market
9.6 Agriculture & Animal Research
9.6.1 Applications In Crop Research & Animal Biotechnology To Boost The Next Generation Sequencing Market
9.7 Other Applications (Marine Research, Research In Bio-Fuels, Forensic Medicine, Phyleogeograpic & Phylogenetic Studies)
10 Next Generation Sequencing Market, By End-User (Page No. – 126)
10.1 Introduction
10.1.1 Research Centers, Academic & Government Institutes
10.1.1.1 NGS Is A Research-Driven Market, Hence Highest Market Share
10.1.2 Hospitals & Clinics
10.1.2.1 Segment To Show Highest Growth Rate
10.1.3 Pharmaceutical & Biotechnology Companies
10.1.3.1 Targeted Therapy, Biomarker Research To Boost Segment Growth
10.1.4 Other End-Users (Npo, Agrigenomics Organizations, Consumer Genomic Companies)
11 Next Generation Sequencing Market, By Geography (Page No. – 133)
11.1 Introduction
11.2 North America
11.2.1 Government Funding To Boost The U.S. Market
11.2.2 Funds By Canadian Government Strives To Boost Next Generation Sequencing Market
11.3 Europe
11.3.1 Germany,U.K., And Belgium Are The Hubs For Scientific Research
11.3.2 Investments In Rare Disease Research Likely To Boost The NGS Market In Europe
11.3.3 Increasing Funding For Molecular Diagnostics In Europe Is Likely To Propel The Growth Of The Whole Exome Sequencing Market
11.4 Asia
11.4.1 China: Lucrative Market For NGS Products And Services Market
11.4.2 Regular Funding From The Indian Government, An Impetus To The NGS Market
11.5 Rest Of The World (Row)
11.5.1 Bioinformatics & Biotechnology Research In Latin America To Boost The Demand For NGS Instruments & Services
11.5.2 Flourishing Bio-Research Centers & Financial Support In Australia & Brazil Will Propel The Market
12 Competitive Landscape (Page No. – 162)
12.1 Overview
12.2 Market Share Analysis
12.2.1 Global NGS Platform Market
12.3 New Product Launches
12.4 Agreements And Partnerships
12.5 Mergers & Acquisitions
12.6 Expansions
13 Company Profiles (Overview, Financials, Products & Services, Strategy, & Developments)* (Page No. – 172)
13.1 Introduction
13.2 454 Life Sciences Corporation (Roche Holding Ag)
13.2.1 Business Overview
13.2.2 Financials
13.2.3 Products & Services
13.2.4 Strategy
13.2.5 Recent Developments
13.3 Agilent Technologies, Inc.
13.3.1 Business Overview
13.3.2 Financials
13.3.3 Products And Services
13.3.4 Key Strategy
13.3.5 Recent Developments
13.4 Bgi (Beijing Genomics Institute)
13.4.1 Business Overview
13.4.2 Financials
13.4.3 Products & Services
13.4.4 Key Strategy
13.4.5 Recent Developments
13.5 Biomatters, Ltd.
13.5.1 Business Overview
13.5.2 Financials
13.5.3 Products & Services
13.5.4 Key Strategy
13.5.5 Recent Developments
13.6 Clc Bio (Acquired By Qiagen)
13.6.1 Business Overview
13.6.2 Financials
13.6.3 Products & Services
13.6.4 Key Strategy
13.6.5 Recent Developments
13.7 Dnastar, Inc.
13.7.1 Business Overview
13.7.2 Financials
13.7.3 Products & Services
13.7.4 Key Strategy
13.7.5 Recent Developments
13.8 Gatc Biotech Ag
13.8.1 Business Overview
13.8.2 Financials
13.8.3 Products & Services
13.8.4 Key Strategy
13.8.5 Recent Developments
13.9 Genomatix Software Gmbh
13.9.1 Business Overview
13.9.2 Financials
13.9.3 Products & Services
13.9.4 Key Strategy
13.9.5 Recent Developments
13.1 Illumina, Inc.
13.10.1 Business Overview
13.10.2 Financials
13.10.3 Products & Services
13.10.4 Key Strategy
13.10.5 Recent Developments
13.10.6 Swot
13.10.7 Mnm View
13.11 Knome, Inc.
13.11.1 Business Overview
13.11.2 Financials
13.11.3 Products & Services
13.11.4 Key Strategy
13.11.5 Recent Developments
13.12 Life Technologies Corporation (Thermo Fisher Scientific)
13.12.1 Business Overview
13.12.2 Financials
13.12.3 Products & Services
13.12.4 Key Strategy
13.12.5 Recent Developments
13.12.6 Swot
13.12.7 Mnm View
13.13 Macrogen, Inc.
13.13.1 Business Overview
13.13.2 Financials
13.13.3 Products & Services
13.13.4 Key Strategy
13.13.5 Recent Developments
13.14 Oxford Nanopore Technologies, Ltd.
13.14.1 Overview
13.14.2 Financials
13.14.3 Products & Services
13.14.4 Key Strategy
13.14.5 Recent Developments
13.15 Pacific Biosciences
13.15.1 Business Overview
13.15.2 Financials
13.15.3 Products & Services
13.15.4 Key Strategy
13.15.5 Recent Developments
13.15.6 Swot
13.15.7 Mnm View
13.16 Partek Incorporated
13.16.1 Business Overview
13.16.2 Financials
13.16.3 Products & Services
13.16.4 Key Strategy
13.16.5 Recent Developments
13.17 Perkin Elmer, Inc.
13.17.1 Business Overview
13.17.2 Financials
13.17.3 Products & Services
13.17.4 Key Strategy
13.17.5 Recent Developments
13.18 Qiagen N.V.
13.18.1 Business Overview
13.18.2 Financials
13.18.3 Products & Services
13.18.4 Key Strategy
13.18.5 Recent Developments
*Details On Financials, Product & Services, Strategy, & Developments Might Not Be Captured In Case Of Unlisted Companies.
14 Appendix (Page No. – 233)
14.1 Insights Of Industry Experts
14.2 Discussion Guide
14.3 Available Customizations
14.4 Related Reports
14.5 Introducing Rt: Real Time Market Intelligence
【レポート販売概要】
■ タイトル：世界の次世代シーケンシング(NGS)市場：プラットフォーム、バイオインフォマティクス、技術、用途■ 英文：Next Generation Sequencing (NGS) Market by Platforms (Illumina HiSeq, MiSeq, HiSeqX Ten, NextSeq 500,Thermo Fisher Ion Proton/PGM), Bioinformatics (Exome Sequencing, RNA-Seq, ChIP-Seq), Technology (SBS, SMRT) & by Application (Diagnostics, Personalized Medicine) – Global Forecast to 2020
■ 発行日：2014年9月
■ 調査会社：MarketsandMarkets
■ 商品コード：MAM-BT-2697
■ 調査対象地域：グローバル
- 世界の政府部門におけるITサービス及びBPO市場（2014-2018）About IT services help customers to accomplish their requirements and improve the business goals and activities while BPO consists of subcontracting the business processes of an organization to a third-party vendor that has expertise in the required domains. IT and BPO services are required in the Government sector to manage IT systems and improve business-related processes and methodologies. IT a …
- Relapsed Multiple Myeloma（多発性骨髄腫）：グローバル臨床試験動向（2014年上半期）Relapsed Multiple Myeloma Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Relapsed Multiple Myeloma Global Clinical Trials Review, H1, 2014" provides data on the Relapsed Multiple Myeloma clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Relapsed Multiple Myeloma. It includes an overview of the trial …
- グローバル装甲車・対IED防御車両市場（2014-2024）：主要プログラムSynopsis This report provides information on major programs planned in the global Armored and Counter IED Vehicles market. It provides details on top programs in each segment expected to be executed during the forecast period. Summary This report discusses the various programmes conducted by key players in the market, by dividing them into the main types of Armored and Counter IED Vehicles. The re …
- 医療用使い捨て手袋の世界市場2015-2019About Medical Disposable Gloves Medical disposable gloves are used in performing medical procedures and examinations to help prevent possible contamination between healthcare personnel and patients. The gloves are made from different polymers, such as neoprene, latex, vinyl and nitrile rubber, and available in both powdered and powder-free forms. Cornstarch is usually used to lubricate the powdere …
- 世界のスピリッツ（蒸留酒）市場のM&A動向（2014年6月）Synopsis The report provides a review of the mergers and acquisitions (M&As), partnering deals, and agreements entered into by companies active in the global spirits market during June 2014. Summary Using this report, dealmakers will effectively gain an insight into deal activity of the global spirits market throughout the month. Additionally, the report provides an overview of all the partnering, …
- Germinomatous (Seminomatous)胚細胞腫瘍：グローバル臨床試験レビュー（2014年上半期）Germinomatous (Seminomatous) Germ Cell Tumors Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Germinomatous (Seminomatous) Germ Cell Tumors Global Clinical Trials Review, H1, 2014" provides data on the Germinomatous (Seminomatous) Germ Cell Tumors clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Ger …
- 2014年戦略提言：スペインの性行為感染症（STD）診断検査市場About This ReportThis new 280-page report from Venture Planning Group presents detailed analysis of the Spanish STD market, including sales forecasts and supplier shares for Chancroid, Chlamydia, Gonorrhea, Herpes (I/II, VI), Papillomavirus (Pap Smear, HPV), and Syphilis. The report provides test volume and sales projections for Hospitals and Commercial/Private Labs. …
- 世界のスイッチギア市場：Global Switch Gear Market 2014-2018TechNavio's analysts forecast the Global Switch Gear market to grow at a CAGR of 8.53 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increasing demand for renewable sources of energy. The Global Switch Gear market has also been witnessing the steady shift from conventional switch gear to modular switch gear. However, the volatility of crude oil …
- 世界のソーシャルメディア分析市場：コンポーネント別、用途別（販売およびマーケティング管理、カスタマーエクスペリエンス管理、および競合他社情報）、展開モデル別、組織規模別、業種別、地域別The global social media analytics market size is projected to grow at a CAGR of 25.4% during the forecast period The social media analytics market size is projected to grow from USD 3.0 billion in 2019 to USD 9.4 billion by 2024, at a Compound Annual Growth Rate (CAGR) of 25.4% during the forecast period. The social media analytics market is driven by increased focus on competitive intelligence an …
- 世界のガーデニング及びアウトドアリビング市場動向（2014-2018）About Gardening and Outdoor Living Gardening and outdoor living is a leisure activity that involves the practice of growing plants at home. In general, gardening is viewed as a relaxing activity by many individuals. It involves adding ornamental plants and shrubs to a garden to enhance the overall beauty of a home. It also includes growing useful plants and shrubs for food and herbal medicine. In …
- Gastrointestinal Hemorrhage：グローバル臨床試験レビューH1, 2013Gastrointestinal Hemorrhage Global Clinical Trials Review, H1, 2013 Summary GlobalData's clinical trial report, “Gastrointestinal Hemorrhage Global Clinical Trials Review, H1, 2013" provides data on the Gastrointestinal Hemorrhage clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Gastrointestinal Hemorrhage. It includes an overview of t …
- 世界の細胞治療市場及びパイプラインインサイトResearch in cell therapy is transforming the future of medicine. As the life of a human being begins as a cell, these cells undergo a highly complex set of events and finally those few stem become capable of self-renewal and differentiation and develop into the specialized cells in the body. Cell therapy research also offers significant potential for restructuring the method of medical practice. S …
- ビデオゲームの世界市場2019-2023About this market The rising penetration of smartphones and improving Internet access is one of the key factors expected to trigger the market’s growth in the forthcoming years. Mobile gaming is the largest segment of the global video game market and will grow significantly during the forecast period. The continuously increasing availability of low-cost smartphones will further contribute to the g …
- 男性用美容家電の世界市場：電気シェーバー、電気トリマーAbout male grooming products Earlier men used generic unisex brands. However, these days, men prefer to use brands, which are customized as per their skin and age. This change has transformed the entire beauty and personal care industry and every leading consumer products company has ventured to capture male target customers. Customers are no longer restricted to manual grooming products and have …
- 化学機械平坦化（CMP）の世界市場：研磨装置、研磨消耗品Chemical mechanical planarization (CMP) is an enabling technology in the wafer fabrication of integrated circuits and has been widely used in the wafer manufacturing process in different electronic devices such as semiconductors, optoelectronics, and optics for reducing chip size & improving performance. Continuous research & development efforts and associated technological breakthroughs in the ar …
